Newsroom

The White House has just released its latest White House Cancer Moonshot Fact Sheet and ASGE’s signature project on colorectal cancer screening has been featured.

This week, the Federal Trade Commission (FTC) adopted a comprehensive ban on non-compete clauses in employment contracts with no exceptions for the health care industry.

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the U.S. Screening for CRC in average-risk individuals between the ages of 45-75 is vital to decreasing the morbidity and mortality from this potentially deadly disease.

Blue Cross Blue Shield of Massachusetts (BCBSMA) officially postponed its restrictive sedation policy until further notice! This change is retroactive to Jan. 1, 2024.

ASGE has selected Community Health Care Systems, Inc. (CHCS) and the Maryland State Medical Society (MedChi) to administer developmental projects that are designed to increase the follow-up colonoscopy rate.

Lawmakers and health experts urge federal agencies to expand access to life-saving CRC screenings. Lawmakers and healthcare organizations called on the federal government to ensure surveillance colonoscopy is classified as a preventive service.

We are pleased to announce that the GIQuIC Registry has once again been approved as a Qualified Clinical Data Registry (QCDR) for reporting to the Merit‐based Incentive Payment System (MIPS) for the 2024 reporting year.